Ezetimibe 10 MG Oral Tablet — RxCUI 349556
RxNorm drug concept · Semantic clinical drug
RxCUI 349556
Semantic clinical drug · SCD
● Current RxNorm concept 42 FDA products
127 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI349556
Official nameEzetimibe 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped42
Package NDCs mapped127
Reported Medicaid activity (SDUD)1,107,566 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ezetimibe: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. Ezetimibe works in your intestine — it blocks a protein that absorbs cholesterol from your food and bile, so less cholesterol gets into your bloodstream. Statins, o...
- What exactly does ezetimibe do, and how is it different from a statin?
- You can take it at whatever time of day works best for you — morning, evening, whatever you'll remember. Food doesn't affect how well it's absorbed, so with or without a meal is fi...
- Can I take ezetimibe at any time of day, and does it matter if I eat first?
🕸️ Concept Web — How Ezetimibe 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ezetimibe 10 MG Oral Tablet
RxCUI 349556 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ezetimibe
341248IN
-
Ezetimibe
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zetia
353099BN
-
Zetia
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ezetimibe Oral Tablet
378303SCDF -
Ezetimibe Oral Product
1163793SCDG -
Ezetimibe Pill
1163794SCDG -
Ezetimibe Oral Tablet [Zetia]
368566SBDF -
Zetia Oral Product
1187441SBDG -
Zetia Pill
1187442SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Ezetimibe Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ezetimibe 10 MG
350671SCDC -
Ezetimibe 10 MG Oral Tablet [Zetia]
352304SBD -
Ezetimibe 10 MG [Zetia]
576000SBDC
-
Ezetimibe 10 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ezetimibe 10 MG
SCDC · 350671 -
Ezetimibe Oral Tablet
SCDF · 378303 -
Ezetimibe Oral Product
SCDG · 1163793 -
Ezetimibe Pill
SCDG · 1163794
Brand-Name Concepts
-
Ezetimibe 10 MG Oral Tablet [Zetia]
SBD · 352304 -
Ezetimibe 10 MG [Zetia]
SBDC · 576000 -
Ezetimibe Oral Tablet [Zetia]
SBDF · 368566 -
Zetia Oral Product
SBDG · 1187441 -
Zetia Pill
SBDG · 1187442 -
Zetia
BN · 353099
📦 FDA Products & Package NDCs
42 products · 127 package NDCs
127 package NDCs map to RxCUI 349556 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00591-3713-05 | 500 TABLET in 1 BOTTLE (0591-3713-05) | Ezetimibe | Actavis Pharma, Inc. | 2017-06-12 |
| 00591-3713-19 | 90 TABLET in 1 BOTTLE (0591-3713-19) | Ezetimibe | Actavis Pharma, Inc. | 2017-06-12 |
| 00591-3713-30 | 30 TABLET in 1 BOTTLE (0591-3713-30) | Ezetimibe | Actavis Pharma, Inc. | 2017-06-12 |
| 00781-5690-05 | 500 TABLET in 1 BOTTLE (0781-5690-05) | Ezetimibe | Sandoz Inc | 2017-06-12 |
| 00781-5690-31 | 30 TABLET in 1 BOTTLE (0781-5690-31) | Ezetimibe | Sandoz Inc | 2017-06-12 |
| 00781-5690-92 | 90 TABLET in 1 BOTTLE (0781-5690-92) | Ezetimibe | Sandoz Inc | 2017-06-12 |
| 00904-7103-04 | 30 BLISTER PACK in 1 CARTON (0904-7103-04) / 1 TABLET in 1... | Ezetimibe | Major Pharmaceuticals | 2017-12-23 |
| 00904-7103-10 | 20 BLISTER PACK in 1 CARTON (0904-7103-10) / 1 TABLET in 1... | Ezetimibe | Major Pharmaceuticals | 2023-08-25 |
| 10135-0787-05 | 500 TABLET in 1 BOTTLE (10135-787-05) | Ezetimibe | Marlex Pharmaceuticals, Inc. | 2024-01-01 |
| 10135-0787-30 | 30 TABLET in 1 BOTTLE (10135-787-30) | Ezetimibe | Marlex Pharmaceuticals, Inc. | 2024-01-01 |
| 10135-0787-90 | 90 TABLET in 1 BOTTLE (10135-787-90) | Ezetimibe | Marlex Pharmaceuticals, Inc. | 2024-01-01 |
| 16714-0813-01 | 30 TABLET in 1 BOTTLE (16714-813-01) | Ezetimibe | NorthStar Rx LLC | 2021-02-01 |
| 16714-0813-02 | 90 TABLET in 1 BOTTLE (16714-813-02) | Ezetimibe | NorthStar Rx LLC | 2021-02-01 |
| 16714-0813-03 | 500 TABLET in 1 BOTTLE (16714-813-03) | Ezetimibe | NorthStar Rx LLC | 2021-02-01 |
| 16729-0433-10 | 30 TABLET in 1 BOTTLE (16729-433-10) | EZETIMIBE | Accord Healthcare Inc. | 2019-11-01 |
| 31722-0628-01 | 100 TABLET in 1 BOTTLE (31722-628-01) | EZETIMIBE | Camber Pharmaceuticals, Inc. | 2022-07-26 |
| 31722-0628-05 | 500 TABLET in 1 BOTTLE (31722-628-05) | EZETIMIBE | Camber Pharmaceuticals, Inc. | 2023-09-25 |
| 31722-0628-10 | 1000 TABLET in 1 BOTTLE (31722-628-10) | EZETIMIBE | Camber Pharmaceuticals, Inc. | 2023-09-25 |
| 31722-0628-30 | 30 TABLET in 1 BOTTLE (31722-628-30) | EZETIMIBE | Camber Pharmaceuticals, Inc. | 2022-07-26 |
| 31722-0628-31 | 100 BLISTER PACK in 1 CARTON (31722-628-31) / 10 TABLET in... | EZETIMIBE | Camber Pharmaceuticals, Inc. | 2022-07-26 |
| 31722-0628-34 | 100 BLISTER PACK in 1 CARTON (31722-628-34) / 10 TABLET in... | EZETIMIBE | Camber Pharmaceuticals, Inc. | 2022-07-26 |
| 31722-0628-90 | 90 TABLET in 1 BOTTLE (31722-628-90) | EZETIMIBE | Camber Pharmaceuticals, Inc. | 2022-07-26 |
| 33342-0373-07 | 30 TABLET in 1 BOTTLE (33342-373-07) | Ezetimibe | Macleods Pharmaceuticals Limited | 2024-04-29 |
| 33342-0373-10 | 90 TABLET in 1 BOTTLE (33342-373-10) | Ezetimibe | Macleods Pharmaceuticals Limited | 2024-04-29 |
| 33342-0373-15 | 500 TABLET in 1 BOTTLE (33342-373-15) | Ezetimibe | Macleods Pharmaceuticals Limited | 2024-04-29 |
| 50090-3422-00 | 30 TABLET in 1 BOTTLE (50090-3422-0) | Ezetimibe | A-S Medication Solutions | 2018-03-28 |
| 50090-3422-01 | 90 TABLET in 1 BOTTLE (50090-3422-1) | Ezetimibe | A-S Medication Solutions | 2018-04-03 |
| 50090-3657-00 | 30 TABLET in 1 BOTTLE, PLASTIC (50090-3657-0) | Ezetimibe | A-S Medication Solutions | 2017-12-23 |
| 50090-3657-01 | 90 TABLET in 1 BOTTLE (50090-3657-1) | Ezetimibe | A-S Medication Solutions | 2018-10-11 |
| 50090-6630-00 | 30 TABLET in 1 BOTTLE (50090-6630-0) | Ezetimibe | A-S Medication Solutions | 2023-08-25 |
| 50090-6630-01 | 90 TABLET in 1 BOTTLE (50090-6630-1) | Ezetimibe | A-S Medication Solutions | 2023-08-25 |
| 50090-6631-00 | 90 TABLET in 1 BOTTLE (50090-6631-0) | Ezetimibe | A-S Medication Solutions | 2023-08-25 |
| 50090-7099-00 | 90 TABLET in 1 BOTTLE (50090-7099-0) | Ezetimibe | A-S Medication Solutions | 2024-02-22 |
| 50090-7236-00 | 90 TABLET in 1 BOTTLE (50090-7236-0) | Ezetimibe | A-S Medication Solutions | 2024-08-28 |
| 50090-7338-00 | 90 TABLET in 1 BOTTLE (50090-7338-0) | Ezetimibe | A-S Medication Solutions | 2024-10-15 |
| 50090-7339-00 | 30 TABLET in 1 BOTTLE (50090-7339-0) | Ezetimibe | A-S Medication Solutions | 2024-10-15 |
| 50090-7339-01 | 90 TABLET in 1 BOTTLE (50090-7339-1) | Ezetimibe | A-S Medication Solutions | 2024-10-15 |
| 50090-7689-00 | 90 TABLET in 1 BOTTLE (50090-7689-0) | EZETIMIBE | A-S Medication Solutions | 2025-10-10 |
| 50090-7690-00 | 30 TABLET in 1 BOTTLE (50090-7690-0) | EZETIMIBE | A-S Medication Solutions | 2025-10-10 |
| 50090-7690-01 | 90 TABLET in 1 BOTTLE (50090-7690-1) | EZETIMIBE | A-S Medication Solutions | 2025-10-10 |
| 50228-0379-05 | 500 TABLET in 1 BOTTLE (50228-379-05) | Ezetimibe | ScieGen Pharmaceuticals Inc | 2020-10-23 |
| 50228-0379-10 | 1000 TABLET in 1 BOTTLE (50228-379-10) | Ezetimibe | ScieGen Pharmaceuticals Inc | 2020-10-23 |
| 50228-0379-30 | 30 TABLET in 1 BOTTLE (50228-379-30) | Ezetimibe | ScieGen Pharmaceuticals Inc | 2020-10-23 |
| 50228-0379-90 | 90 TABLET in 1 BOTTLE (50228-379-90) | Ezetimibe | ScieGen Pharmaceuticals Inc | 2020-10-23 |
| 50268-0298-12 | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-298-12) / 1 TABL... | Ezetimibe | AvPAK | 2017-07-02 |
| 51660-0200-05 | 500 TABLET in 1 BOTTLE (51660-200-05) | Ezetimibe | Ohm Laboratories Inc. | 2017-06-12 |
| 51660-0200-30 | 30 TABLET in 1 BOTTLE (51660-200-30) | Ezetimibe | Ohm Laboratories Inc. | 2017-06-12 |
| 51660-0200-90 | 90 TABLET in 1 BOTTLE (51660-200-90) | Ezetimibe | Ohm Laboratories Inc. | 2017-06-12 |
| 59651-0052-05 | 500 TABLET in 1 BOTTLE (59651-052-05) | Ezetimibe | Aurobindo Pharma Limited | 2017-08-25 |
| 59651-0052-30 | 30 TABLET in 1 BOTTLE (59651-052-30) | Ezetimibe | Aurobindo Pharma Limited | 2017-08-25 |
Observed labelers:
Bryant Ranch Prepack (30) ·
A-S Medication Solutions (15) ·
Proficient Rx LP (10) ·
Camber Pharmaceuticals, Inc. (7) ·
Zydus Lifesciences Limited (6) ·
Zydus Pharmaceuticals USA Inc. (6)
· +19 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.0691
Range $0.0691–$13.9772
· middle 50% $0.0691–$0.0691
· 36 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.